Key result
The extent and severity of fixed or reversible dipyridamole thallium perfusion defects did not predict the occurrence of perioperative cardiovascular complications.
Why the study?
Does dipyridamole thallium imaging improve risk stratification for major cardiovascular complications in patients undergoing major vascular surgery compared to clinical evaluation alone?
Population
115 patients evaluated before major vascular surgery, stratified into high-risk and low-risk cohorts
Comparison
Dipyridamole thallium imaging vs Careful clinical evaluation
Design
Cohort
Follow-up
perioperative
Authors
Loading...
Thallium imaging does not improve perioperative risk stratification beyond clinical assessment in vascular surgery; leaves open whether alternative modalities add value.
Cohort (n=115)
Does dipyridamole thallium imaging improve risk stratification for major cardiovascular complications in patients undergoing major vascular surgery compared to clinical evaluation alone?
Dipyridamole thallium imaging does not reliably predict perioperative cardiovascular complications beyond clinical risk assessment in high-risk patients undergoing major vascular surgery.
Costello et al. (1993) conducted a cohort in Major vascular surgery (n=115). Dipyridamole thallium imaging was evaluated on Major cardiovascular complications. The extent and severity of fixed or reversible dipyridamole thallium perfusion defects did not predict the occurrence of perioperative cardiovascular complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: